CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

BIIBBIOGEN INC.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $225.88 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$33.37B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-05 · Godbout Sean (Chief Accounting Officer) · OTHER
  • 2026-08-05 · Minor Lloyd (Director) · SELL
  • 2026-06-11 · Patolawala Monish D (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders1,127
Shares held175,526,007
Value$36.47B
Percent of shares outstanding118.80%
As of quarter end2026-09-30
RECENT CONGRESSIONAL TRADES
  • 2026-09-24 · Hon. Maria Elvira Salazar · SELL · $1,001 - $15,000
  • 2026-08-18 · Kevin Hern · SELL · $1,001 - $15,000
  • 2026-06-05 · Gilbert Cisneros · BUY · $1,001 - $15,000
  • 2026-06-02 · Maria Elvira Salazar · SELL · $15,001 - $50,000
  • 2026-05-12 · Maria Elvira Salazar · BUY · $1,001 - $15,000
RECENT NEWS
  • JPMorgan gets bullish on Biogen ahead of 2027 catalysts
  • Why is Biogen stock climbing today?
  • JPMorgan upgrades Biogen with $300 price target
  • Biogen’s big lupus bet gets boost from new durability data for skin disease
  • Biogen phase 2 litifilimab data boosts lupus candidate
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
BIOGEN INC. (BIIB) · Stock Price, Insider Trades, Congress Trades · CatalystPit